DaVita Inc
NYSE:DVA
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
99.26
165.51
|
Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one DVA stock under the Base Case scenario is 226.71 USD. Compared to the current market price of 165.51 USD, DaVita Inc is Undervalued by 27%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation Backtest
DaVita Inc
Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Start backtest now and learn if your stock is truly undervalued or overvalued!
Stock is trading at its lowest valuation over the past 5 years.
To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.
The backtest for DVA cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.
Fundamental Analysis
Select up to 3 indicators:
Select up to 3 indicators:
Months
Months
Months
Months
Select up to 2 periods:
DaVita Inc. has emerged as a leading healthcare provider specializing in kidney care, operating over 2,800 outpatient dialysis centers across the United States and 10 additional countries. Founded in 1994, the company has made significant strides in enhancing the quality of life for individuals battling chronic kidney disease. With a mission deeply rooted in patient care, DaVita focuses on delivering comprehensive treatment and support, ensuring that patients receive not only dialysis services but also vital education and resources for managing their condition. This commitment to patient-centric care has positioned DaVita as a notable player in the burgeoning healthcare sector, making it an...
DaVita Inc. has emerged as a leading healthcare provider specializing in kidney care, operating over 2,800 outpatient dialysis centers across the United States and 10 additional countries. Founded in 1994, the company has made significant strides in enhancing the quality of life for individuals battling chronic kidney disease. With a mission deeply rooted in patient care, DaVita focuses on delivering comprehensive treatment and support, ensuring that patients receive not only dialysis services but also vital education and resources for managing their condition. This commitment to patient-centric care has positioned DaVita as a notable player in the burgeoning healthcare sector, making it an attractive investment opportunity for those interested in the resilience and growth potential within the industry.
From an investor's perspective, DaVita represents a blend of stability and growth potential, driven by an aging population that increasingly requires kidney care services. The company benefits from a favorable reimbursement landscape and has implemented operational efficiencies that enhance profitability. In recent years, DaVita has also ventured into value-based care initiatives, which align incentives towards improved patient outcomes rather than volume. This strategic pivot not only secures a sustainable revenue model but also highlights the company’s adaptability in a rapidly changing healthcare environment. As such, DaVita stands out in the investment community, offering a chance to capitalize on a vital sector poised for expansion, all while contributing to the well-being of countless patients.
DaVita Inc. is a prominent healthcare company primarily focused on providing dialysis services for patients with chronic kidney failure and end-stage renal disease (ESRD). Here are the core business segments of DaVita:
-
Dialysis Services: This is the primary business segment of DaVita, encompassing in-centre dialysis, home dialysis, and supportive services. DaVita operates numerous outpatient dialysis centers across the United States where patients receive treatment for kidney failure. Home dialysis options, including peritoneal dialysis and home hemodialysis, are also offered, providing patients with flexibility and autonomy.
-
Kidney Care: DaVita extends beyond dialysis services to encompass comprehensive kidney care management. This includes care coordination, integrated care delivery, and management of comorbid conditions associated with chronic kidney disease. The company works with nephrologists and healthcare providers to enhance patient outcomes and efficiency in care delivery.
-
Dialysis Products: While the primary focus is on services, DaVita offers a range of dialysis-related products to enhance the treatment experience. This segment includes the development and distribution of medical equipment and supplies necessary for dialysis procedures.
-
Population Health Management: DaVita is involved in population health initiatives aimed at improving overall healthcare outcomes for patients with chronic kidney disease. This segment focuses on preventive care, early intervention, and the management of a patient’s overall health status, coordinating with various healthcare providers.
-
International Operations: Although primarily focused on the U.S., DaVita also has operations in various international markets, providing dialysis services to patients outside the United States. This segment is less significant than their domestic operations but represents an area of potential growth and diversification.
DaVita's business model emphasizes delivering high-quality patient care, improving the patient experience, and maintaining cost efficiencies while navigating the complexities of the healthcare landscape.
DaVita Inc. holds several unique competitive advantages that set it apart from its rivals in the healthcare industry, particularly in the dialysis sector. These advantages include:
-
Established Brand Reputation: DaVita has built a strong brand presence and reputation in the dialysis market, recognized for quality patient care and a commitment to improving patient outcomes.
-
Extensive Network: DaVita operates a large network of dialysis centers across the United States and internationally, allowing for economies of scale, greater market penetration, and improved accessibility for patients.
-
Integrated Care Model: The company utilizes an integrated care model that includes comprehensive services not only for dialysis but also for related healthcare needs, allowing for better patient management and satisfaction.
-
Patient-Centric Services: DaVita emphasizes personalized care and services tailored to individual patient needs, which can lead to better patient retention and loyalty.
-
Strong Relationships with Insurers: The company has established partnerships with various health insurers and payers, facilitating smoother reimbursement processes and potentially better contract terms.
-
Investment in Technology: DaVita has made significant investments in technology and data analytics, allowing for improved operational efficiency, better patient tracking, and enhanced treatment protocols.
-
Research and Development: Ongoing research and development efforts help DaVita stay at the forefront of new treatment methodologies, improving patient outcomes and maintaining competitive differentiation.
-
Skilled Workforce: The company boasts a highly trained and experienced workforce committed to providing exceptional care, which enhances operational effectiveness and patient experiences.
-
Community Focus: DaVita has a strong community presence and engages in various outreach programs, enhancing its brand image and fostering trust within the communities it serves.
-
Strategic Acquisitions: DaVita has a track record of strategic acquisitions to bolster its market position, thereby increasing its service offerings and geographic reach.
These competitive advantages position DaVita Inc. favorably in the healthcare market and enable it to maintain a strong position against its rivals.
DaVita Inc., a leading provider of kidney care and dialysis services, faces several risks and challenges in the near future:
-
Regulatory Changes: The healthcare sector is heavily regulated, and any changes in government policies, including Medicare and Medicaid reimbursement rates, can significantly impact DaVita's profitability. Proposed changes at both federal and state levels could lead to reduced payments for services.
-
Reimbursement Rates: Ongoing pressures to reduce healthcare costs may lead to cuts in dialysis reimbursement rates or changes in coverage, affecting DaVita’s revenue. The company relies heavily on reimbursements from government programs and private insurers.
-
Competition: The dialysis market is competitive, with several providers vying for market share. DaVita faces competition from both large national chains and smaller regional providers. New entrants could also disrupt market dynamics.
-
Patient Volume Fluctuations: Changes in patient demographics, healthcare policies, or improvements in treatments for chronic kidney disease could influence patient volume adversely. A decline in the number of patients needing dialysis could impact revenue.
-
Operational Challenges: Given the nature of dialysis services, any operational inefficiencies, staffing shortages, or supply chain disruptions could hamper service delivery and patient care.
-
Litigation Risk: DaVita has faced legal challenges in the past related to its billing practices and treatment methodologies. Ongoing or new litigation could lead to financial risks and damage to its reputation.
-
Technological Changes: The shift toward home dialysis and advancements in treatment technology could impact DaVita's traditional in-center services. The company must adapt swiftly to these changes to maintain its market position.
-
Economic Factors: Broader economic factors, including inflation and changes in consumer spending behavior, can affect the company's operations and revenue generation. Economic downturns may prompt patients to delay or forgo treatments.
-
Talent Acquisition and Retention: The healthcare workforce is under significant strain, leading to challenges in attracting and retaining qualified personnel in a competitive labor market. A shortage of skilled staff can directly affect the quality of patient care.
-
Public Perception and Reputation: As a healthcare provider, DaVita's business relies heavily on its reputation. Any negative publicity or patient dissatisfaction could lead to a loss of trust and reduced patient enrollment.
Addressing these risks through strategic planning and proactive management will be crucial for DaVita Inc. to navigate the evolving healthcare landscape successfully.
Revenue & Expenses Breakdown
DaVita Inc
Balance Sheet Decomposition
DaVita Inc
Current Assets | 4B |
Cash & Short-Term Investments | 1.1B |
Receivables | 2.6B |
Other Current Assets | 313.9m |
Non-Current Assets | 13.5B |
Long-Term Investments | 464.3m |
PP&E | 5.4B |
Intangibles | 7.4B |
Other Non-Current Assets | 219m |
Current Liabilities | 2.9B |
Accounts Payable | 488.2m |
Accrued Liabilities | 1.2B |
Other Current Liabilities | 1.2B |
Non-Current Liabilities | 14.2B |
Long-Term Debt | 9.3B |
Other Non-Current Liabilities | 4.9B |
Earnings Waterfall
DaVita Inc
Revenue
|
12.7B
USD
|
Cost of Revenue
|
-8.5B
USD
|
Gross Profit
|
4.2B
USD
|
Operating Expenses
|
-2.3B
USD
|
Operating Income
|
1.9B
USD
|
Other Expenses
|
-1.1B
USD
|
Net Income
|
827.7m
USD
|
Free Cash Flow Analysis
DaVita Inc
USD | |
Free Cash Flow | USD |
In the third quarter, DaVita reported an adjusted operating income of $535 million and earnings per share of $2.59, indicating stability despite challenges like hurricanes impacting treatment volume and supply disruptions. The company projects revenue growth per treatment to remain between 3.5% and 4%, and confirmed 2024 adjusted operating income guidance of $1.91 billion to $2.01 billion. Although headwinds persist, notably from elevated mortality and supply chain issues, DaVita's strong operational performance and disciplined capital strategies position them favorably for continued growth, including a full-year treatment volume increase of 0.5% to 1%.
What is Earnings Call?
DVA Profitability Score
Profitability Due Diligence
DaVita Inc's profitability score is 65/100. The higher the profitability score, the more profitable the company is.
Score
DaVita Inc's profitability score is 65/100. The higher the profitability score, the more profitable the company is.
DVA Solvency Score
Solvency Due Diligence
DaVita Inc's solvency score is 36/100. The higher the solvency score, the more solvent the company is.
Score
DaVita Inc's solvency score is 36/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
DVA Price Targets Summary
DaVita Inc
According to Wall Street analysts, the average 1-year price target for DVA is 162.96 USD with a low forecast of 138.49 USD and a high forecast of 195.3 USD.
Dividends
Current shareholder yield for DVA is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Ownership
DVA Insider Trading
Buy and sell transactions by insiders
Period | Sold | Bought | Net |
---|---|---|---|
3 Months |
|
|
|
6 Months |
|
|
|
9 Months |
|
|
|
12 Months |
|
|
|
Profile
Country
Industry
Market Cap
Dividend Yield
Description
DaVita, Inc. engages in the provision of medical care services. The company is headquartered in Denver, Colorado and currently employs 69,000 full-time employees. The firm's principal business is to provide dialysis and related lab services to patients. The company is engaged in providing care delivery, referred to as United States (U.S.) dialysis business. The firm also operate various ancillary services, including its international operations, as well as its corporate administrative support. Its U.S. dialysis business is a provider of kidney dialysis services for patients suffering from chronic kidney failure, also known as end stage renal disease (ESRD) or end stage kidney disease (ESKD). The firm's ancillary services consist primarily of integrated care and disease management, clinical research programs and physician services, as well as its international operations. The firm's international dialysis operations provides dialysis and administrative services through a total of 333 outpatient dialysis centers located in ten countries outside of the United States.
Officers
The intrinsic value of one DVA stock under the Base Case scenario is 226.71 USD.
Compared to the current market price of 165.51 USD, DaVita Inc is Undervalued by 27%.